The Signos platform combines a continuous glucose monitor with an artificial intelligence-based app to guide users regarding food and movement.

In its most recent round of layoffs, Dexcom cuts 3% of its global workforce, targeting mostly San Diego-based employees.

An overview of key considerations shaping the BGM and CGM decision, why both often coexist in trials today, and how eCOA ...

Dexcom, the San Diego-based maker of continuous glucose monitors for diabetes patients and prediabetics, announced Wednesday ...

Glucose monitoring has long been associated with diabetes management, but a wave of new biosensors promises insights for people without the condition too. The idea: by tracking your blood sugar in ...

A combination of a lower-calorie Mediterranean diet, exercise and nutritional support kept overweight to severely obese ...

Metabolic syndrome severity is a meaningful marker of chronic kidney disease risk even when patients do not have other major ...

From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D).

Enjoying these foods to help manage blood sugar on a regular basis could lower your risk of developing type 2 diabetes, ...

Acetone may be best known as a sharp-smelling solvent found in nail polish remover, but inside your body it can tell an ...

Use of an automated insulin delivery system that combines an insulin pump with a disposable sensor improved time in range and ...

The Signos Glucose Monitoring System is a mobile device application that receives data from an over-the-counter integrated continuous glucose monitor, the Dexcom Stelo Biosensor. Paired together, the ...